Literature DB >> 11139464

Extracellular matrix remodeling: multiple paradigms in vascular disease.

E A Turley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139464     DOI: 10.1161/01.res.88.1.2

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  6 in total

Review 1.  Possible mechanical roles of glycosaminoglycans in thoracic aortic dissection and associations with dysregulated transforming growth factor-β.

Authors:  J D Humphrey
Journal:  J Vasc Res       Date:  2012-09-25       Impact factor: 1.934

Review 2.  Cardiovascular gene delivery: The good road is awaiting.

Authors:  L P Brewster; E M Brey; H P Greisler
Journal:  Adv Drug Deliv Rev       Date:  2006-07-07       Impact factor: 15.470

Review 3.  Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic Aneurysms.

Authors:  Georgia Skotsimara; Alexios Antonopoulos; Evangelos Oikonomou; Charalampos Papastamos; Gerasimos Siasos; Dimitrios Tousoulis
Journal:  Inflammation       Date:  2022-01-25       Impact factor: 4.092

4.  HAS-1 genetic polymorphism in sporadic abdominal aortic aneurysm.

Authors:  Chiara Armani; Stefano Landi; Marco Nuti; Rossella Di Stefano; Alberto Balbarini
Journal:  Heart Int       Date:  2009-06-30

5.  Photoelasticity-based evaluation of cellular contractile force for phenotypic discrimination of vascular smooth muscle cells.

Authors:  Shukei Sugita; Eri Mizutani; Masatoshi Hozaki; Masanori Nakamura; Takeo Matsumoto
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

6.  Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model.

Authors:  Daisuke Kitano; Suguru Migita; Yuxin Li; Rie Takahashi; Yoshiki Taniguchi; Takafumi Kurosawa; Mitsumasa Sudo; Hironori Haruta; Takafumi Hiro; Tadateru Takayama; Masako Mitsumata; Taro Matsumoto; Yasuo Okumura; Atsushi Hirayama
Journal:  J Atheroscler Thromb       Date:  2020-11-18       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.